Red blood cell pathogen reduction: in search of serological agnosticism

被引：5

作者：

Benjamin, R. J. ^{[1
]}

机构：

[1] Amer Red Cross, Blood Serv, Washington, DC 20006 USA

来源：

ISBT SCIENCE SERIES, VOL 1, NO 1: STATE OF THE ART PRESENTATIONS | 2006年 / 1卷 / 01期

关键词：

D O I：

10.1111/j.1751-2824.2006.00035.x

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：222 / 226

页数：5

共 40 条

[1] SEN virus: epidemiology and characteristics of a transfusion-transmitted virus [J].

Akiba, J ;

Umemura, T ;

Alter, HJ ;

Kojiro, M ;

Tabor, E .

TRANSFUSION, 2005, 45 (07) :1084-1088

[2] Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction [J].

AuBuchon, JP ;

Herschel, L ;

Roger, J ;

Taylor, H ;

Whitley, P ;

Li, JZ ;

Edrich, R ;

Goodrich, RP .

TRANSFUSION, 2005, 45 (08) :1335-1341

[3] Pathogen inactivation in cellular blood components: Clinical trials and implications of introduction to transfusion medicine [J].

AuBuchon, JP .

VOX SANGUINIS, 2002, 83 :271-275

[4] Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study [J].

AuBuchon, JP ;

Pickard, CA ;

Herschel, LH ;

Roger, JC ;

Tracy, JE ;

Purmal, A ;

Chapman, J ;

Ackerman, S ;

Beach, KJ .

TRANSFUSION, 2002, 42 (02) :146-152

[5] Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients [J].

Benjamin, RJ ;

McCullough, J ;

Mintz, PD ;

Snyder, E ;

Spotnitz, WD ;

Rizzo, RJ ;

Wages, D ;

Lin, JS ;

Wood, L ;

Corash, L ;

Conlan, MG .

TRANSFUSION, 2005, 45 (11) :1739-1749

[6]

BENJAMIN RJ, 2003, EMERGING TECHNOLOGIE, P287

[7]

BUDOWSKY EI, 2000, Patent No. 6136586

[8]

Chapman J, 2002, BLOOD, V100, p142B

[9]

Ciaravino V, 2002, BLOOD, V100, p143B

[10] Preclinical safety of a nucleic acid-targeted Helinx™ compound:: A clinical perspective [J].

Ciaravino, V .

SEMINARS IN HEMATOLOGY, 2001, 38 (04) :12-19

← 1 2 3 4 →